1. An update to terminology describing abnormal uterine bleeding in female athletes: facilitating cross-disciplinary health care.
- Author
-
Oleka CT, Anderson T, Ackerman KE, Elliott-Sale KJ, Kraus E, Casey E, Stellingwerff T, Donaldson AT, Finnoff JT, Post EG, and Adams WM
- Abstract
Competing Interests: Competing interests: Conflict of Interest Statement: KEA receives research funding from the Joe and Clara Tsai Foundation as part of the Wu Tsai Human Performance Alliance and from Nike. She receives speaker and writer honoraria from Gatorade Sports Science Institute, Hologic, Springer and UptoDate. She is a deputy editor of the British Journal of Sports Medicine and an associate editor of the British Journal of Sports Medicine’s Injury Prevention and Health Protection Edition. KJE-S has received funding/honoraria from Arsenal Football Club, The UK Sports Institute, the European Club Association, Gatorade Sport Science Institute, Hologic, Science in Sport and the UK Ministry of Defence to support female athletes. TS has received funding/honoraria from the Wu Tsai Human Performance Alliance, Ineos, Science in Sport (Sis) Own The Podium, Gatorade Sport Science Institute and Lululemon Athletica to support research, including projects on female participants. JTF receives royalties from UptoDate and Demos Publishing. WMA serves on the advisory board for My Normative, where he receives stock options as compensation for his efforts. WMA is a member of the Sport Advisory Council for the Wu Tsai Human Performance Alliance. WMA also receives royalties from Springer Nature. EK receives research funding from the Joe and Clara Tsai Foundation as part of the Wu Tsai Human Performance Alliance. None of the above honoraria and funds have a direct competing interest with the content of this editorial. CTO, TA, EC, AD, EGP and EC have nothing to disclose.
- Published
- 2024
- Full Text
- View/download PDF